Cassava Sciences (NASDAQ:SAVA) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Cassava Sciences (SAVA) operate in?

Cassava Sciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Cassava Sciences Stock (NASDAQ: SAVA) stock price, news, charts, stock research, profile.

Open	$3.40
Close	-
Volume / Avg.	5.99M / 4.41M
Day Range	$3.25 - $3.55
52 Wk Range	3.40 - 42.20
Market Cap	$166.70M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	23
Short Interest	40.11%
Days to Cover	11.62

Recent News

Benzinga Bulls And Bears: Amazon, Tesla, Rivian, Palantir And How Dogecoin Helped Low-Income Families Achieve Homeownership

Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a look at some of our top stories.

Michael Cohen

This Goldman Sachs Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Avi Kapoor

Cassava Sciences, Zoom, Kohl's, Rivian, Tesla: Why These 5 Stocks Are On Investors' Radars Today

SAVA, ZM, KSS, RIVN, TSLA were among the trending stocks among investors on Monday Nov. 25, 2024.

Benzinga Neuro

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jul

Aug

Oct

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$3.40
Close	-
Volume / Avg.	5.99M / 4.41M
Day Range	$3.25 - $3.55
52 Wk Range	3.40 - 42.20
Market Cap	$166.70M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	23
Short Interest	40.11%
Days to Cover	11.62

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Cassava Sciences (SAVA) stock?

You can purchase shares of Cassava Sciences (NASDAQ:SAVA) through any online brokerage.

View our list of the best stock brokerages

Who are Cassava Sciences (SAVA) competitors?

Other companies in Cassava Sciences’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Telomir Pharmaceuticals (NASDAQ:TELO), Trevi Therapeutics (NASDAQ:TRVI), Milestone Pharmaceuticals (NASDAQ:MIST) and Nektar Therapeutics (NASDAQ:NKTR).

What is the forecast, or price target, for Cassava Sciences (SAVA) stock?

Cassava Sciences has a consensus price target of $89.00.

What is the current price for Cassava Sciences (SAVA)?

The stock price for Cassava Sciences (NASDAQ: SAVA) is $3.465 last updated December 3, 2024 at 1:34 PM EST.

Does Cassava Sciences (SAVA) pay a dividend?

A quarterly cash dividend of 0.75 per share of Class A Common Stock. The quarterly cash dividend was payable on December 24, 2012 to stockholders of record on December 13, 2012.

When is Cassava Sciences (NASDAQ:SAVA) reporting earnings?

Cassava Sciences’s Q4 earnings are confirmed for Wednesday, February 26, 2025.

Is Cassava Sciences (SAVA) going to split?

There is no upcoming split for Cassava Sciences.

What sector and industry does Cassava Sciences (SAVA) operate in?

Cassava Sciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

Cassava Sciences

Cassava Sciences (SAVA) Forecast